Bone News and Research

RSS

Cancer cells that break away from tumors may prefer to settle into soft bed

Cancer cells that break away from tumors to go looking for a new home may prefer to settle into a soft bed, according to new findings from researchers at the University of Illinois.

8 Aug 2014

Molecule Notch involved in fear memory formation

Nature is thrifty. The same signals that embryonic cells use to decide whether to become nerves, skin or bone come into play again when adult animals are learning whether to become afraid.

7 Aug 2014

Akron collaborates with Vivex Biomedical on use of next-generation line of cryopreservation media

Akron is pleased to announce that it secured a strategic collaboration with Vivex Biomedical, Inc. on the use of its next-generation line of cryopreservation media, CryoNovo™.

7 Aug 2014

More and more patients are opting for dental implants, says dentist

A National Health and Nutrition Examination Survey administered by the Centers for Disease Control & Prevention found that 25 percent of patients over 60 years old have lost all of their teeth. It's estimated that 63% of all American adults are missing more than one tooth.

7 Aug 2014

Novel therapy takes rheumatoid arthritis treatment in mice to a new level

Rheumatoid arthritis is a condition that causes painful inflammation of several joints in the body. The joint capsule becomes swollen, and the disease can also destroy cartilage and bone as it progresses. Rheumatoid arthritis affects 0.5% to 1% of the world's population. Up to this point, doctors have used various drugs to slow or stop the progression of the disease.

7 Aug 2014

Penn State health educator recommends new car seat guidelines for children

Keeping up with car seat rules and regulations can be dizzying. Laws vary from state to state, and they can differ from recommendations of the National Highway Traffic Safety Administration and American Academy of Pediatrics. Those recommendations, in turn, can differ from car seat manufacturer's instructions. It's no wonder parents may be confused.

7 Aug 2014

CTI BioPharma's pacritinib granted FDA Fast Track designation for treatment of myelofibrosis

CTI BioPharma Corp. announced today that pacritinib has been granted Fast Track designation by the U.S. Food and Drug Administration for the treatment of intermediate and high risk myelofibrosis, including but not limited to patients with disease related thrombocytopenia, patients experiencing treatment emergent thrombocytopenia on other JAK2 therapy or patients who are intolerant to or whose symptoms are sub-optimally managed on other JAK2 therapy.

7 Aug 2014

Immunosuppressive drugs increase risk of myeloid disorders among IBD patients

Immunosuppressive drugs called thiopurines have been found to increase the risk of myeloid disorders, such as acute myeloid leukemia and myelodysplastic syndrome, a rare bone marrow disorder, seven-fold among inflammatory bowel disease (IBD) patients.

7 Aug 2014

States of Maine and Rhode Island add SCID to newborn screening panels

The Immune Deficiency Foundation commends the states of Maine and Rhode Island for adding Severe Combined Immune Deficiency to their states' newborn screening panels, effective August 1, 2014. These states join 21 other states currently screening newborns for SCID, ensuring over two thirds of all babies in the U.S. are now being screened.

5 Aug 2014

Researchers postulate similarities between changes in cells and origins of triple negative breast cancer

Healthy breast cells may be able to reinvent themselves -- some have the flexibility to change after they are mature -- which leads researchers to postulate that similarities exist between this occurrence and the origins of a particularly aggressive type of breast cancer.

5 Aug 2014

New spinal fixation technique: an interview with Dr. Ian Armstrong, Medical Director, Southern California Spine Institute

Traditionally, the most commonly used medical devices for spinal fusion procedures have been pedicle screws and rods, and interbody cages or spacers. Each are coupled with bone grafts and limit movement while the area being fused heals.

4 Aug 2014

Phase 3 ASPIRE clinical trial meets primary endpoint of progression-free survival

Amgen and its subsidiary, Onyx Pharmaceuticals, Inc., today announced that a planned interim analysis demonstrated that the Phase 3 clinical trial ASPIRE (CArfilzomib, Lenalidomide, and DexamethaSone versus Lenalidomide and Dexamethasone for the treatment of PatIents with Relapsed Multiple MyEloma) met its primary endpoint of progression-free survival (PFS).

4 Aug 2014

New information on limitations and potential for development of transcranial ultrasound therapy

A recent study completed at the University of Eastern Finland provides new information on the limitations and potential new directions for the future development of transcranial ultrasound therapy.

4 Aug 2014

ACAAI offers practical solutions to improve asthma problem in older women

Women over the age of 65 face numerous barriers to good health: an increased risk for obesity, greater struggles against poverty and higher rates of asthma with worse health outcomes.

4 Aug 2014

Modulation of B cells may effectively treat symptoms of type 2 diabetes and periodontitis

Going to the dentist isn't fun for anyone, but for those with periodontal disease related to type 2 diabetes, a new research discovery may have them smiling.

1 Aug 2014

Blood-forming stem cell transplantation benefits infants with severe combined immunodeficiency

Babies who are born with severe combined immunodeficiency (SCID) can be successfully treated with a transplant of blood-forming stem cells, according to experts led by Memorial Sloan Kettering's Richard J. O'Reilly, MD, a world-renowned pioneer in the development of transplant protocols.

31 Jul 2014

FDA approves use of Imbruvica to treat patients with chronic lymphocytic leukemia

The U.S. Food and Drug Administration today expanded the approved use of Imbruvica (ibrutinib) to treat patients with chronic lymphocytic leukemia (CLL) who carry a deletion in chromosome 17 (17p deletion), which is associated with poor responses to standard treatment for CLL. Imbruvica received a breakthrough therapy designation for this use.

29 Jul 2014

EMA CHMP adopts positive opinion for Janssen’s IMBRUVICA to treat CLL and MCL

Janssen-Cilag International NV announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency adopted a positive opinion recommending the granting of a marketing authorisation for IMBRUVICA (ibrutinib) in the European Union.

29 Jul 2014

Researchers examine role of dairy products in preserving bone and skeletal muscle

Understanding that diets are often built around food groups rather than specific nutrients, researchers from Switzerland, France, and North America decided to examine interactions between four nutrients found in dairy products and their role in preserving bone and skeletal muscle.

29 Jul 2014

Fitnessedge.net adds new articles on using hGH peptides for anti-aging, hGH replacement therapy

Fitnessedge.net, a website that is devoted to offering readers the most up-to-date information about various weight loss programs, has just added some new and educational articles on using hGH peptides for anti-aging and hGH replacement therapy.

26 Jul 2014

Bone News and Research

Cancer cells that break away from tumors may prefer to settle into soft bed

Molecule Notch involved in fear memory formation

Akron collaborates with Vivex Biomedical on use of next-generation line of cryopreservation media

More and more patients are opting for dental implants, says dentist

Novel therapy takes rheumatoid arthritis treatment in mice to a new level

Penn State health educator recommends new car seat guidelines for children

CTI BioPharma's pacritinib granted FDA Fast Track designation for treatment of myelofibrosis

Immunosuppressive drugs increase risk of myeloid disorders among IBD patients

States of Maine and Rhode Island add SCID to newborn screening panels

Researchers postulate similarities between changes in cells and origins of triple negative breast cancer

New spinal fixation technique: an interview with Dr. Ian Armstrong, Medical Director, Southern California Spine Institute

Phase 3 ASPIRE clinical trial meets primary endpoint of progression-free survival

New information on limitations and potential for development of transcranial ultrasound therapy

ACAAI offers practical solutions to improve asthma problem in older women

Modulation of B cells may effectively treat symptoms of type 2 diabetes and periodontitis

Blood-forming stem cell transplantation benefits infants with severe combined immunodeficiency

FDA approves use of Imbruvica to treat patients with chronic lymphocytic leukemia

EMA CHMP adopts positive opinion for Janssen’s IMBRUVICA to treat CLL and MCL

Researchers examine role of dairy products in preserving bone and skeletal muscle

Fitnessedge.net adds new articles on using hGH peptides for anti-aging, hGH replacement therapy

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News